cefoperazone has been researched along with Chemotherapy-Induced Febrile Neutropenia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cyriac, SL; Dubashi, B; Harish, BH; Jadhav, N; Jaffa, E; Kayal, S; Matta, KK; Pattnaik, J; Pillai, US; Ponraj, M; Prakash, B; Ranjith, K; Singh, J | 1 |
1 trial(s) available for cefoperazone and Chemotherapy-Induced Febrile Neutropenia
Article | Year |
---|---|
Cefepime vs. cefoperazone/sulbactam in combination with amikacin as empirical antibiotic therapy in febrile neutropenia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antineoplastic Agents; Cefepime; Cefoperazone; Cephalosporins; Chemotherapy-Induced Febrile Neutropenia; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Neoplasms; Sulbactam; Survival Analysis; Withholding Treatment; Young Adult | 2018 |